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Abstract
Objects To study the long-term outcome of surgically
treated low-grade cerebellar astrocytomas in children.
Materials and methods We followed 31 consecutive
patients under 16 years of age who were diagnosed between
1980 and 2005 in a single institution. In 21 of 31 survivors
(median follow-up time 7.9 years; range 5.6–27.4 years)
who agreed to participate, tumor control, neurological and
cognitive complications, and their impact on behavioral and
emotional adjustment and health-related quality of life
(HRQoL) were comprehensively assessed qualitatively
and quantitatively.
Results Neurological sequelae were found in 43%. How-
ever, age-appropriate ability to perform daily life activities
was normal in all patients. Remarkably, cognitive deficits
leading to significant school problems occurred in 19% and
behavioral and emotional adjustment disturbances in 27%.
In comparison with healthy controls, the survivors rated
their HRQoL similarly or even higher.
Conclusion Childhood low-grade cerebellar astrocytomas
have an excellent cure rate by tumor surgery alone. When
compared with other pediatric brain tumors, the risk of
neurological, cognitive, emotional, and behavioral compli-
cations is relatively small. HRQoL is similar to that of
healthy controls.
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Introduction
Low-grade astrocytomas comprise approximately 30–40%
of all primary brain tumors in childhood. For low-grade
cerebellar astrocytomas, surgery represents the treatment of
choice. Despite their benign biological nature, low-grade
cerebellar astrocytomas can cause not only permanent
neurological damages such as truncal ataxia, dysmetria,
nystagmus, and dysarthria [1, 2] but also behavioral and
emotional problems and deficits in several cognitive
functions including attention, memory, processing speed,
interference, and verbal fluency [1–7]. These cognitive and
behavioral impairments represent the cerebellar cognitive
affective syndrome initially described by Schmahmann and
Sherman [8] in adults and subsequently expanded to the
pediatric age. What is not yet sufficiently documented is the
impact that such late effects have on the quality of life
(QoL) of the survivors [9].
Interest in the measurement of QoL has expanded
considerably over the past 10 years, with an increasing
understanding of the importance of patients’ perspectives
[10]. According to the World Health Organization (WHO
1948), health-related quality of life (HRQoL) is seen as a
multidimensional concept including physical, social, cog-
nitive, and emotional functioning. The subjective percep-
tion and appraisal of functioning are as important as
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objective health because individuals with the same objec-
tive health status can report very different QoL [11]. For
assessing HRQoL in pediatric populations, there is wide
agreement that instruments should be multidimensional,
sensitive to cognitive development, and easy to complete
and should encompass the broadest age range possible.
Furthermore, they should meet the required psychometric
parameters of sensitivity, reliability, and validity [12–14].
As an extension of our previous studies on outcome in
pediatric low-grade cerebellar astrocytomas [1], we fol-
lowed 31 consecutive patients at a single hospital diagnosed
between 1980 and 2005.
Material and methods
Patient selection
Between January 1980 and December 2005, 31 patients
below the age of 16 years with cerebellar low-grade
astrocytoma were diagnosed at the University Children’s
Hospital of Zurich, Switzerland. All diagnoses were
confirmed by histological assessment of a tumor specimen
obtained at surgery. Clinical information on the 31 patients
included date of birth, date of diagnosis, therapy received,
and follow-up. Gross total resection was defined as
complete tumor removal as reported by the operating
neurosurgeon and confirmed by postoperative neuroimaging
(magnetic resonance imaging or computed tomography). The
median age of all patients at diagnosis was 8.1 years (range
2.4–15.5 years). As of October 2007, 30 of the 31 patients
were alive. Seven patients could not be contacted because
they had moved to another country and three patients refused
to participate. To our knowledge, two of these patients had
no neurological sequelae, whereas one had mild truncal
ataxia and ocular movement disorder. The remaining 21
patients agreed to be interviewed and to be assessed by
quantitative measures. Eleven patients were female and ten
were male. The median age at diagnosis of the study patients
was 7.8 years (range 2.4–14.3 years) and the median age at
assessment was 15.8 years (range 8.3–41.0 years). Six
patients (patient nos. 4, 7, 9, 11, 12, and 15) were included
in an article focused on neuropsychological findings ([1];
patient nos. 3, 4, 5, 13, 14, and 19). Approval to perform the
study and to link study data to clinical data was obtained
from the Institutional Review Board.
Semistructured interview
After receiving the written informed consent of parents and
patients, the questionnaires were posted to the patients and
the interview was performed by telephone. Combined with
the information obtained from medical notes, the data
gathered from the interview were intended to give a
descriptive picture of the participant’s past and present life
situation. Therefore, the interview included questions about
the time of diagnosis and treatment, current medication,
physical and visual functioning, height and weight, satis-
faction with physical appearance, emotional functioning,
and interpersonal relationships including school perfor-
mance, personal interests, social activities, thoughts, family
relations, intimate relationships, and wishes about the future
(“Appendix”). The questions were phrased in an easily
comprehensible way and almost every question had a yes–
no answer.
Youth Self-Report, Child Behavior Checklist, and Brief
Symptom Inventory
German versions of the Youth Self-Report (YSR) [15, 16]
and the Child Behavior Checklist (CBCL) [17, 18] were
used to assess behavioral and emotional problems. Details
about these instruments have been published in our
previous studies on outcome in craniopharyngioma, medul-
loblastoma, and intraspinal tumors [19–21]. YSR and
CBCL were used in the present study for nine patients
aged between 12 and 20 years (median age 15.8 years). To
assess emotional health in older patients, we used a German
version of the 53-item Brief Symptom Inventory (BSI),
which includes symptoms over the previous 7 days [22,
23]. The BSI includes three global indices of distress and
nine symptom dimensions. Raw scores were converted to T
scores based on healthy population norms and dichoto-
mized using a cut point of 63. Those with T scores >62
were classified as having poor emotional health. BSI was
used in the present study for ten patients aged between 15
and 41 years (median age 22.6 years).
Fertigkeitenskala Munster–Heidelberg Abilities Scale
To assess the ability to perform daily life actions, the
German Fertigkeitenskala Munster–Heidelberg Abilities
Scale (FMH) was used [24]. Details about this instrument
have been published in our previous study on outcome in
craniopharyngioma [19]. FMH was used in the present
study for all patients.
Pediatric Quality of Life Inventory
A German version of the Pediatric Quality of Life
Inventory (PedsQL™) was used to measure HRQoL [25,
26]. Details about this questionnaire have been published in
our previous studies [19, 20, 27]. In the present study, the
PedsQL™ 4.0 Generic Core Scales were used for all
patients (n=21). The scores of the study population were
compared with the published scores of 401 healthy controls
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[28] by single sample T tests. Spearman correlation
coefficients were calculated to explore the relationship
between self-rated and parent-rated PedsQL™ scores and
clinical factors. P values <0.05 were considered significant.
Results
Local tumor control and relapse-free interval
The median follow-up time of all 31 patients following
diagnosis was 6.8 years (range 0.1 to 27.4 years). The 10-year
overall survival was 96.2% and the 10-year progression-free
survival was 100% as determined by the Kaplan–Meier
method (Fig. 1). One patient (diagnosed in the year 1982)
died postoperatively with complications due to infection.
For the 21 study patients, median follow-up time was 7.9
years (range 5.6–27.4 years; Table 1). The tumors were
located in the cerebellar hemispheres (11 on the right side,
eight on the left) and/or midline (n=10). Gross total tumor
resection was achieved in 19 of 21 patients and incomplete
resection in two. In these two patients, the residual tumor
was immediately removed. Histology in 20 cases revealed
pilocytic astrocytoma WHO I and in one case an astrocy-
toma WHO II. In all patients, the therapeutic approach
consisted of surgery alone. Tumor relapse occurred in one
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Fig. 1 The Kaplan–Meier curves show the probability of overall
survival (a) and progression-free survival (b) for 31 children with low-
grade cerebellar astrocytoma
Table 1 Comparison of FMH scores and PedsQL™ scores with clinical factors of 21 children with cerebellar low-grade astrocytoma
Patient no. Age at
diagnosis
(years)
Gender Tumor
location
Tumor
resection
VP
shunt
Relapse Tumor
reoperation
Follow-up
(years)
FMH
(centile)
PedsQL™
(self-rated)
PedsQL™
(parent-rated)
1 2.4 Female R→ML Total No No No 11.8 25–50 90.22 92.39
2 2.7 Female L→ML Total No No No 5.6 50–75 86.96 80.43
3 3.8 Female L→ML Subtotal Yes No Yesa 6.9 25–50 98.91 98.91
4 4.3 Male L→ML Total No No No 18.5 25–50 75.00
5 4.3 Female R Total No No No 21.8 50–75 82.61
6 5.1 Female R→ML Total No No No 6.7 25–50 77.17 70.65
7 5.2 Male ML Subtotal No No Yesa 10.6 50–75 97.83 82.61
8 5.7 Male R Total No No No 4.3 25–50 83.70 83.70
9 5.7 Male ML Total No No No 9.8 25–50 98.91 98.91
10 6.7 Female L→ML Total No No No 2.8 50–75 91.30 97.83
11 7.8 Male L→ML Total No No No 14.8 50–75 77.17
12 8.1 Male L→ML Total No No No 7.8 25–50 97.83 96.74
13 8.1 Male R Total Yes No No 2.3 10–25 82.61 81.52
14 9.1 Male R Total No No No 3.3 25–50 83.70 71.74
15 9.8 Female R Total No No No 15.1 90–95 71.74
16 11.1 Male R Total No No No 1.9 25–50 93.48 92.39
17 11.9 Female R Total No No No 9.2 25–50 81.52
18 12.3 Female R Total No No No 4.6 50–75 98.91 97.83
19 13.5 Male L Total No No No 6.6 50–75 61.96 94.57
20 13.7 Male R Total Yes Yes Yes 27.4 25–50 72.83
21 14.3 Female L Total No No No 11.4 50–75 92.39
L Left cerebellar hemisphere, R right cerebellar hemisphere, ML midline
a Immediate reoperation because of incomplete primary tumor resection
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patient 10.5 years after initial diagnosis (patient no. 20); the
recurrent tumor was totally removed surgically. Postopera-
tively, three patients required the insertion of a ventriculo-
peritoneal shunt.
Assessment of disabilities and their impact on HRQoL
Together with the information obtained from the medical
notes, the data gathered from the patients’ physicians, the
patients’ parents, as well as from the patients themselves
served to provide a description of the patients’ disabilities
and their past and present life situation. Table 2 summarizes
this information. Three patients had disorders not related to
the cerebellar tumor: one patient (no. 15) with a positive
familiar history for epilepsy suffered from photosensitive
epilepsy with generalized seizures 7 years after diagnosis.
Another patient (no. 21) suffered from back pain after a
herniated vertebral disk, and a third patient (no. 1) had a
transposition of the great arteries that required cardiac
surgery.
Neurological sequelae
Nine of 21 patients (42%) had significant neurological
sequelae that persisted during long-term follow-up. These
sequelae included limb ataxia (n=8; 38%), truncal ataxia (n=
6; 28%), dysarthria (n=1; 5%), and ocular movement
disorders (n=1; 5%). Four patients (nos. 2, 11, 13, 16) were
having physiotherapy or occupational therapy at the time of
follow-up. One patient (no. 10) had speech therapy and two
patients (no. 13, 14) had psychological support.
Cognitive function, school performance, and occupation
Seven (33%) of the 21 study patients had difficulties in
concentrating (attention deficit). Six patients (28%) de-
scribed processing speed deficits. Significant school or
occupational problems occurred in four (19%) patients: two
patients attended a special school, another one had to repeat
a school year and the fourth attended a supported
workplace.
Physical functioning
Four (19%) of the 21 patients complained about frequent
headaches. Two patients (10%) were not satisfied with their
physical appearance: the first because of a visible scar on
the neck and the second because of a facial asymmetry. All
patients confirmed no impairment in physical fitness and
none of them used orthotics.
Daily life activities
Twenty (95%) of 21 study patients had FMH scores above
the 25th centile indicating normal age-appropriate ability to
perform daily life activities. One of the 21 study patients
had FMH scores below the 25th centile and none of the
scores were below the fifth centile (Table 1).
Table 2 Disabilities and
quality of life of 21 long-term
survivors with low-grade
cerebellar astrocytoma
a Only >19 years of age
Characteristics Affected patients Limiting quality of life
Neurological functioning
Limb ataxia 8/21 5/8
Truncal ataxia 6/21 3/6
Dysarthria 1/21 0/1
Ocular movement disorders 1/21 0/1
Paresis 0/21
Neurocognitive, school and occupation functioning
Impaired intelligence 4/21 4/4
Attention deficit 7/21 5/7
Processing speed deficit 6/21 5/6
Remedial teaching 4/21 1/4
Impaired choice of occupationa 1/8 1/1
Physical functioning
Frequent headache 4/21 3/4
Not satisfied with physical appearance 3/21 2/3
Impaired fitness 0/21
Emotional and social functioning
Behavioral problems 7/21 5/7
Difficulties in making friends 4/21 4/4
No partnership experiencea 3/8 2/3
Impaired independencea 0/8
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Behavioral and emotional problems, social life
Based on interviews and clinical records, seven (33%) of
the 21 study patients had behavioral problems. Most of
them described sadness, anxiety, or general emotional
instability. One patient reported aggressive and destructive
behavior since diagnosis. In all cases, the symptoms led to
unconfident behavior in social live. Four adult patients
described difficulties in making friends, which resulted in
social isolation. Two females (age 25 years) never had any
partnership experience, which was limiting their QoL.
Subjective behavior and emotional problems were
assessed by YSR and BSI, dependent on age. Four (26%)
of 15 investigated patients had clinically significant total
scores. Summarizing the results of both tests, six patients
showed significant scores in obsessive or paranoid behav-
ior, four patients in interpersonal sensitivity, anxiety, or
depression, four patients in delinquent, hostile, or aggres-
sive behavior, two patients in somatic complaints, and one
patient in attention problems. Seven of the 15 patients did
not demonstrate clinical significance in any of the subscale
scores (Fig. 2).
Based on the parent-rated CBCL, one (11%) of nine
survivors had a significant total score. The same patient had a
significant score in attention problems. A second patient had
significant subscores in internalizing, anxiety–depression, and
withdrawal but not a significant total score.
Health-related quality of life
In comparison with healthy controls, the patients with
cerebellar astrocytoma rated their HRQoL similar or even
better (Fig. 3). Notably, patients with cerebellar astrocytoma
rated their physical health higher than did healthy controls
(93.01 vs. 84.41; p<0.001). Concordance between patient
and parent ratings was relatively good.
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Fig. 2 a Behavioral and psychological adjustment problems as rated by
the patients with low-grade cerebellar astrocytoma (n=9; Youth Self-
Report) and their parents (n=9; Child Behavior Checklist). The numbers
of patients with clinically significant scores are shown. b Brief
Symptom Inventory in survivors of low-grade cerebellar astrocytoma
(n=10). The BSI includes three global indices of distress and nine
symptom dimensions. Raw scores were converted to T scores based on
healthy population norms and dichotomized using a cut point of 63.
Those with T scores >62 were classified as having poor emotional
health
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Fig. 3 Health-related quality of life in survivors of low-grade
cerebellar astrocytoma rated by the patients and their parents using
the PedsQL™ 4.0 Generic Core. Horizontal lines are mean values;
solid box shows 25th to 75th centiles; whisker bars represent lowest
and highest values. For self-report and parental rating controls,
horizontal lines are means; there are no boxes or whisker plots
because data were not available
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Discussion
Low-grade cerebellar astrocytomas are histologically be-
nign tumors with very good tumor control achieved by
surgery alone. Ten-year progression-free survival rates
range from 81% to 93% [29–31]. In our series, surgery
alone was largely successful in disease control. The 10-year
progression-free survival was 100% and tumor relapse was
observed in only one patient 10.5 years after initial
diagnosis. With improved survival rates in pediatric brain
tumors, awareness of significant tumor-related and/or
therapy-related long-term neurological, cognitive, emotional,
or behavioral complications has increased [32–36].
An increasing number of clinical studies has demonstrated
cognitive deficits in children with posterior fossa tumors. These
long-term problems have been described by Schmahmann
and Sherman [8] as “cerebellar cognitive affective syndrome,”
confirming the importance of the cerebellum for nonmotor
functions. The cerebellar cognitive affective syndrome is
characterized by problems of executive function, impaired
spatial cognition, linguistic difficulties, and personality
changes. In two subsequent pediatric series of patients who
underwent resection of a cerebellar tumor without additional
therapy, Levisohn et al. [4] and Riva and Giorgi [5] described
impairments in planning and sequencing, visual–spatial
functions, expressive language, verbal memory, and modula-
tion of affect. In a comparable study population, Steinlin et al.
reported significant problems for attention, memory, process-
ing speed, and interference. Furthermore, visuoconstrictive
abilities and verbal fluency were also affected. Behavioral
deficits could be detected in 33% of patients and attention
deficits were marked in 12.5% [1]. In a similar study, Aarsen
et al. [2, 3] found that approximately 61% of children with
low-grade astrocytomas showed impairments in interpersonal
relationship, school functions, and behavior. Our study
confirms these previous findings concerning neurological
and cognitive impairments in long-term survivors of cerebel-
lar tumors. Indeed, in the present study, 43% of the patients
showed persistent neurological sequelae including limb and/or
truncal ataxia, dysarthria, and ocular movement disorders.
Attention and processing speed deficits occurred in 33% and
significant school problems in 19%, confirming the abnor-
malities in neuropsychological subscales described in the
literature [1, 4, 5]. When compared with survivors of
childhood medulloblastoma and craniopharyngioma [19,
20], these changes were rather discreet: the ability to perform
daily life activities was age appropriate in all patients.
Social functioning was rated by the patients and the
parents as seldom impaired. Only four of 21 patients (19%)
had difficulties in making friends, and rejection by peers
was not considered to be a problem. This is in contrast with
the results of our previously published studies in medullo-
blastoma and craniopharyngioma long-term survivors
[19, 20]. Indeed, survivors of both medulloblastomas and
craniopharyngiomas reported internalizing behavior prob-
lems in particular, with significant social problems. Survi-
vors of both medulloblastomas and craniopharyngiomas
showed physical sequelae of the tumor and/or its therapy
such as alopecia, short stature, or obesity. These somatic
problems can cause dissatisfaction with physical appear-
ance and significant social withdrawal. However, survivors
of cerebellar astrocytomas do not show physical sequelae.
This fact may partly explain why social problems in
survivors of cerebellar astrocytomas are less significant
than in survivors of other brain tumors. Significant total
scores of subjective behavior and emotional problems were
found in four of 15 (26%) patients investigated. The
behaviors that were described by the patients included
anxiety, depression, and interpersonal sensitivity but also
particularly psychoticism, hostility, and delinquent and
aggressive behavior. These different neurobehavioral pro-
files could be grouped into two domains, reflecting either
exaggeration or diminution of responses to the internal or
external environment. Schmahmann et al. described these
opposite behaviors in adults and children with both
congenital and acquired cerebellar disorders as “dysmetria
of thought” [37]. Impaired regulation of affect including
irritability or impulsivity has been reported also by other
long-term studies in survivors of cerebellar tumors [1, 4, 5].
According to the parent-rated CBCL, only one patient
had a clinically significant total score of behavioral
problems. On the internalizing behavior problems sub-
scales, parents’ ratings are more often clinically significant
than patients’ ratings. Similar results have been reported in
survivors of other brain tumors [19, 20]. However, on the
externalizing behavior problems subscales, parents’ ratings
are less clinically significant than patients’ ratings. These
findings contrast with the results published in studies about
long-term survivors of other brain tumors [19, 20].
HRQoL of the 21 patients was analyzed by a self-
reported, well-established HRQoL measure. Interestingly,
patients with low-grade cerebellar astrocytomas rated their
HRQoL as normal as or even higher than healthy controls.
This is clearly in contrast to studies about HRQoL in
patients with medulloblastomas and craniopharyngioma
[19, 20]. These findings are also apparent in contrast with
several published studies reporting long-term neurocogni-
tive disturbances in children after surgery for cerebellar
astrocytomas. It seems that long-term neurocognitive and
behavioral problems (which are also noticed in some of our
patients) have only a minimal impact on subjective quality
of life. Emotional dysregulation was reported in acquired
cerebellar lesions [37]. It is possible that this can modify
the patient’s judgement of their own quality of life. In
addition, coping might play an important role. Adaptive
mechanisms have also been considered in tetraplegic
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patients following spinal cord injury, unexpectedly report-
ing better than average quality of life [38].
To our knowledge, this is the first study which
comprehensively evaluates tumor control, functional and
behavioral outcome, and their impact on social life and
HRQoL in a population of patients with cerebellar
astrocytomas treated with surgery alone. However, we are
aware of important limitations in this study: the sample size
is small; formal neuropsychological testing has not been
performed in all patients, and two different tests were used
for behavioral assessment because of age group limitations
for each test. Despite a good quality of life after cerebellar
astrocytoma treatment, careful long-term neurocognitive
follow-up is needed in order to inform parents and teachers
about the behavioral and cognitive sequelae and to
contribute to timely social and educational intervention.
We believe that this study will not only help to acknowl-
edge the problems these survivors have to live with but also
the good prognosis in terms of quality of life.
Appendix I: Semistructured interview questions
Diagnosis
How much do you know about your disease? Did you, or
do you, take a particular interest in it?
Is there anything concerning your disease which is
difficult for you? If yes, what?
Is there anything concerning your disease which was
difficult for you and which you now consider to be less
difficult? Or vice versa?
Present medication
Do you take any medicine now? Which ones? Are there
medicines which you have taken in the past and which you
do not take any more?
Are you disturbed by having to take these medicines
every day?
Do you have, or have you had, any side effects due to
the therapy?
Physical appearance
Are you satisfied with your appearance? What disturbs you
most about your appearance? If you could, would you
change anything about your appearance? If yes, what?
General body fitness–cognitive functions
Do you feel your physical ability is affected by your
illness? How much?
Do you take part in any sport? Which one? Is there
any sport you like but which you cannot take part
in?
Can you concentrate well at school, at work? Do you
believe your ability to concentrate has been impaired by
your illness? What about your speed in solving tasks or in
understanding new things?
Do you often have gaps in your memory?
Emotions
What positive feelings do you have towards your illness?
What negative feelings about your illness?
Are you afraid of getting ill again?
School
Which school do you or did you attend?
How do you get on at school? Do you have any
difficulties? If so, are they due to your illness? Do you
like going to school? If yes, why?
How often do you not attend school?
Do you feel comfortable in your class?
Did anything change in your relationship to your
schoolmates after your illness? If yes, what?
Have people in your school or at work been informed
about your illness? Did you tell them about it?
Job
Which job did you train for or would you like to train for?
Is this the job of your dreams?
Have you started an apprenticeship? Did you finish it? If
not, why?
Did you, or do you, attend university?
What work do you do now? Are you happy with it? If
not, why?
Did you have any other job before? Why did you change
your job?
Hobbies
Do you have any hobbies? What are they?
Do you pursue your hobbies alone or with friends?
Are you a member of any club?
Do you play music?
Have you got a particularly strong interest in anything?
Do you have a pet?
Social situation
Do you live with your parents, with friends, or alone?
Do you live in a special home (hostel)?
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How is your relationship with your parents or brothers
and sisters? Do you often get angry with them? Would you
prefer to live away from home?
Do you have a girlfriend or boyfriend or have you ever
had one?
If you have no relationship: do you miss it? Can you
imagine your future without a partner?
Do you have a good boyfriend or girlfriend? Are you in
touch with him or her? How often?
How do you relate to your teachers–schoolmates–
colleagues?
How do you relate to the doctor treating you? Who is he
or she? Does he or she support you? Does he or she give
enough time to you? Does he or she explain to you what he
or she is going to do?
Are you independent in your daily life? Do you need
help with particular things?
What is your source of income (wages–parents–state)?
Do you receive a benefit? If yes, would you prefer any
other source of income?
Future
How do you see your future?
What would you most like to happen?
Additional comments
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